Ocugen (OCGN) Current Deferred Revenue (2014 - 2018)
Ocugen posted quarterly Current Deferred Revenue of $45000.0 for Q4 2018, up 28.57% year-on-year from $35000.0 in Q4 2017, and down 99.1% on a QoQ basis from $5.0 million in Q3 2018.
Ocugen (OCGN) has 5 years of Current Deferred Revenue data on file, last reported at $45000.0 in Q4 2018.
- For the quarter ending Q4 2018, Current Deferred Revenue rose 28.57% year-over-year to $45000.0; the trailing twelve-month figure through Dec 2018 stood at $45000.0 (up 28.57% YoY), and the FY2018 full-year result was $45000.0, up 28.57% from the prior year.
- Current Deferred Revenue for Q4 2018 stood at $45000.0, down from $5.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $5.0 million in Q3 2018 and bottomed at $35000.0 in Q4 2017.
- The 5-year median for Current Deferred Revenue is $131000.0 (2016), against an average of $469647.1.
- The widest annual swing landed in 2017, when Current Deferred Revenue plunged 91.4%; it then jumped 8233.33% in 2018.
- A 5-year view of Current Deferred Revenue shows it stood at $219000.0 in 2014, then surged by 85.84% to $407000.0 in 2015, then changed by 0.0% to $407000.0 in 2016, then slumped by 91.4% to $35000.0 in 2017, then advanced by 28.57% to $45000.0 in 2018.
- The last three Current Deferred Revenue figures came in at $45000.0 (Q4 2018), $5.0 million (Q3 2018), and $40000.0 (Q2 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 45,000.00 |
| Sep 30, 2018 | 5.00 Mn |
| Jun 30, 2018 | 40,000.00 |
| Mar 31, 2018 | 37,000.00 |
| Dec 31, 2017 | 35,000.00 |
| Sep 30, 2017 | 60,000.00 |
| Jun 30, 2017 | 86,000.00 |
| Mar 31, 2017 | 110,000.00 |
| Dec 31, 2016 | 407,000.00 |
| Sep 30, 2016 | 133,000.00 |
| Jun 30, 2016 | 131,000.00 |
| Mar 31, 2016 | 128,000.00 |
| Dec 31, 2015 | 407,000.00 |
| Sep 30, 2015 | 225,000.00 |
| Jun 30, 2015 | 407,000.00 |
| Mar 31, 2015 | 514,000.00 |
| Dec 31, 2014 | 219,000.00 |